节点文献

糖尿病血管重构机制及其药物防治的研究进展

Research progress of vascular remodeling mechanism and drug prevention in diabetes mellitus

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 仝婉昱Oduro Patrick Kwabena王芳李玉红黎瑞巧冷玲王启隆

【Author】 TONG Wanyu;ODURO Patrick Kwabena;WANG Fang;LI Yuhong;LI Ruiqiao;LENG Ling;WANG Qilong;Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine;State Key Laboratory of Component-Based Chinese Medicine;

【通讯作者】 王启隆;

【机构】 天津中医药大学中医药研究院组分中药国家重点实验室

【摘要】 糖尿病是以高血糖为特征的代谢性疾病,糖尿病相关的代谢异常可引起一系列血管并发症,是糖尿病患者死亡的主要原因。糖尿病诱导的血管重构和功能异常是糖尿病血管并发症的主要原因。糖尿病治疗药物二甲双胍、钠-葡萄糖协同转运蛋白2抑制剂、胰高血糖素样肽1受体激动剂、二肽基肽酶4抑制剂以及天然产物和传统中药均可改善血管重构和功能异常,并显著降低糖尿病患者的死亡率。本文对糖尿病血管重构、血管功能障碍的病理机制以及药物疗法的研究进行综述。

【Abstract】 Diabetes mellitus is a metabolic disease characterized by hyperglycemia.Diabetes-related metabolicabnormalities can lead to a series of vascular complications, which are the main cause of death in patients with diabetes.Vascular remodeling and dysfunction induced by diabetes are the main causes of diabetic vascular complications.Met-formin, sodium-glucose cotransporter type 2 inhibitor, glucagon-like peptide 1 receptor agonist, dipeptidyl peptidase 4 in-hibitor, and natural products and traditional Chinese medicine improve vascular remodeling and dysfunction, and signifi-cantly reduce mortality in patients with diabetes.In this review, emerging and latest pathobiological mechanisms andpharmacological targets and treatments for diabetic vascular remodeling and vascular dysfunction are discussed.

【基金】 国家自然科学基金资助项目(81973624);天津市自然科学基金(19JCYBJC28200);天津市科技计划项目(20ZYJDJC00070,21ZYJDJC00070)
  • 【文献出处】 中南医学科学杂志 ,Medical Science Journal of Central South China , 编辑部邮箱 ,2022年01期
  • 【分类号】R587.1
  • 【被引频次】4
  • 【下载频次】629
节点文献中: 

本文链接的文献网络图示:

本文的引文网络